Autologous hematopoietic cell transplantation non-Hodgkin's lymphoma: 100 month follow-up

Bone Marrow Transplantation

Volumn 29, Issue 8, 2002, Pages 673-679

  Bolwell, B J ^a   Kalaycio, M ^a   Sobecks, R ^a   Andresen, S ^a   Mcbee, M ^a   Kuczkowski, L ^a   Rybicki, L ^a   Pohlman, B ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Autologous bone marrow transplant; Non Hodgkin's lymphoma

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER GRADING; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMATOPOIETIC CELL; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SIDE EFFECT; AUTOTRANSPLANTATION; DISEASE FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; TIME;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LYMPHOMA, HIGH-GRADE; LYMPHOMA, INTERMEDIATE-GRADE; LYMPHOMA, LOW-GRADE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; HUMANS; MIDDLE AGED;

EID: 0036015542     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703525     Document Type: Article

References (30)

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
2. Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients achieving remission: A report from the Autologous Blood and Marrow Registry
3. Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma
4. Survival benefit of high-dose chemotherapy in poor risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 Protocol - A groupe d'etude des lymphomes de l'adulte study
5. Prognostic factors for treatment outcome in autotransplantation of intermediate grade with high grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide
6. High-dose therapy and autologous bone marrow transplantation after failure of chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma
7. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma
8. Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma
9. High-dose therapy with autologous hematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre
10. Effect of follicularity on autologous transplantation for large cell non-Hodgkin's lymphoma
11. Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)
12. High dose chemotherapy with autologous hematopoietic rescue for follicular low grade non-Hodgkin's lymphoma
13. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor prognosis follicular lymphoma
14. High-dose therapy with peripheral blood progenitor cell transplantation in low grade non-Hodgkin's lymphoma
15. Durability of remission after ABMT for NHL: The importance of the 2-year evaluation point
16. National Cancer Institute Sponsored Study of Classifications of Non-Hodgkin's Lymphoma's, Summary and Description of a Working Formulation for Clinical Usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project
17. A predictive model for aggressive non-Hodgkin's lymphoma
18. Survival after relapse of low grade non-Hodgkin's lymphoma: Implications for marrow transplantation
19. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients
20. Follicular lymphoma: Prognostic factors for response and survival
21. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II
22. Retrospective analysis of stage I and stage II indolent lymphomas at the National Cancer Institute
23. Clinical stage I non-Hodgkin's lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy
24. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University
25. High-dose chemotherapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up
26. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma
27. High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: Results of a phase II clinical trial
28. Therapy related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor cell support for lymphoid malignancies
29. Secondary leukaemia and myelodysplasia after autografting for lymphoma: Results from the EBMT
30. Editorial: Myelodysplasia and acute leukemia after autologous bone marrow transplantation